| [1] |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
|
| [2] |
WIDSCHWENDTER A, BÖTTCHER B, RIEDL D, et al. Recurrence of genitals warts in pre-HPV vaccine era after laser treatment[J]. Arch Gynecol Obstet, 2019, 300(3):661-668.
DOI
PMID
|
| [3] |
BRUNI L, DIAZ M, CASTELLSAGUÉ X, et al. Cervical human papillomavirus prevalence in 5 continents:meta-analysis of 1 million women with normal cytological findings[J]. J Infect Dis, 2010, 202(12):1789-1799.
|
| [4] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
|
| [5] |
PERKINS R B, WENTZENSEN N, GUIDO R S, et al. Cervical cancer screening:a review[J], JAMA, 2023, 330(6):547-558.
|
| [6] |
YANG X, LI Y, TANG Y, et al. Cervical HPV infection in Guangzhou,China:an epidemiological study of 198 111 women from 2015 to 2021[J]. Emerg Microbes Infect, 2023, 12(1):e2176009.
|
| [7] |
SHIMIZU A, YAMAGUCHI R, KURIYAMA Y. Recent advances in cutaneous HPV infection[J]. J Dermatol, 2023, 50(3):290-298.
|
| [8] |
CROSIGNANI P, DE STEFANI A, FARA G M, et al. Towards the eradication of HPV infection through universal specific vaccination[J]. BMC Public Health, 2013, 13:642.
DOI
PMID
|
| [9] |
ZHANG R, VELICER C, CHEN W, et al. Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grades 1 or worse among 4215 Chinese women in a population-based study[J]. Cancer Epidemiol, 2013, 37(6):939-945.
DOI
PMID
|
| [10] |
LI Z, LIU F, CHENG S, et al. Prevalence of HPV infection among 28 457 Chinese women in Yunnan province,southwest China[J]. Sci Rep, 2016, 6:21039.
|
| [11] |
CHEN X, XU H, XU W, et al. Prevalence and genotype distribution of human papillomavirus in 961 029 screening tests in southeastern China(Zhejiang province)between 2011 and 2015[J]. Sci Rep, 2017, 7(1):14813.
|
| [12] |
CHEN X, WALLIN K L, DUAN M, et al. Prevalence and genotype distribution of cervical human papillomavirus(HPV)among women in urban Tianjin,China[J]. J Med Virol, 2015, 87(11):1966-1972.
|
| [13] |
LEVI J E, FERNANDES S, TATENO A F, et al. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women[J]. Gynecol Oncol, 2004, 92(1):225-231.
DOI
PMID
|
| [14] |
HERRERO R, HILDESHEIM A, BRATTI C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica[J]. J Natl Cancer Inst, 2000, 92(6):464-474.
DOI
PMID
|
| [15] |
CUSCHIERI K S, CUBIE H A, WHITLEY M W, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population[J]. J Clin Pathol, 2004, 57(1):68-72.
DOI
PMID
|
| [16] |
BOSCH F X, LORINCZ A, MUÑOZ N, et al. The causal relation between human papillomavirus and cervical cancer[J]. J Clin Pathol, 2002, 55(4):244-265.
DOI
PMID
|
| [17] |
VAN DER GRAAF Y, MOLIJN A, DOORNEWAARD H, et al. Human papillomavirus and the long-term risk of cervical neoplasia[J]. Am J Epidemiol, 2002, 156(2):158-164.
PMID
|
| [18] |
PISTA A, OLIVEIRA A, VERDASCA N, et al. Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women[J]. Clin Microbiol Infect, 2011, 17(6):941-946.
|
| [19] |
FIFE K H, CRAMER H M, SCHROEDER J M, et al. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia[J]. J Med Virol, 2001, 64(4):550-559.
PMID
|
| [20] |
VIVES A, COSENTINO M, PALOU J. The role of human papilloma virus test in men:first exhaustive review of literature[J]. Actas Urol Esp(Engl Ed), 2020, 44(2):86-93.
|
| [21] |
PLOTZKER R E, VAIDYA A, POKHAREL U, et al. Sexually transmitted human papillomavirus:update in epidemiology,prevention,and management[J]. Infect Dis Clin North Am, 2023, 37(2):289-310.
|
